subjective outcomes between tibialis anterior allografts and patellar tendon allografts. The quadriceps tendon, while historically reserved for revision reconstructions, has enjoyed a renewed focus as a versatile and durable graft for primary reconstructions. Use of the quadriceps tendon usually does not result in the same degree of anterior knee pain postoperatively, and quadriceps tendon harvest produces a reliably thick, robust graft. The quadriceps tendon has approximately 20% greater collagen per cross-sectional area than the patellar tendon, and a greater diameter of usable soft tissue is available. Bridge Enhanced ACL Restoration (BEAR Implant) A new approach to treating ACL tears was developed at Boston Children's Hospital and is currently in clinical trials. The Bridge Enhanced ACL Restoration (BEAR) implant is a bio-engineered bridging implant that is injected with a small amount of patient's own blood to stimulate healing and reconnection of the ACL. Results from the first-in-human study published in March 2019 in the Orthopedic Journal of Sports Medicine showed the 10 patients who received the BEAR implant had similar clinical, functional and patient-reported outcomes as the 10 patients undergoing autograft ACL reconstruction. Additional clinical studies are underway. Ligament Advanced Reinforcement System (LARS) The anterior cruciate ligament (ACL) of the knee is commonly injured. There is insufficient re-vascularization of the ligament after complete rupture, which limits its ability to heal and necessitates reconstruction surgery. Within the last 20 years, new types of synthetic ligaments have been developed. The Ligament Advanced Reinforcement System (LARS), is one of these new synthetic ligaments that has recently gained popularity. There is evidence that supports LARS as a viable option for reconstruction surgery in regards to complication rates and high patient satisfaction scores, when compared to traditional surgical techniques. However, systematic reviews of the LARS in regarding graft stability and long term functional outcomes, have highlighted several important gaps in existing literature that requires future investigation. The necessity of rehabilitation following LARS is well recognized, but there is limited evidence available that guide rehabilitation protocols. Stem cell treatment Autologous stem-cell transplantation using mesenchymal stem cells (MSCs) has been used to improve recovery time from ACL surgery, especially for athletes. MSCs are multipotent stem cells, meaning they can differentiate into multiple cell types. In the case of mesenchymal stem cells, these cell types include osteoblasts (bone cells), adipocytes (fat cells), and chondrocytes (cartilage cells). Ligament tissue mainly consists of fibroblasts and extracellular matrix. Ligament cells differ in